Relypsa Email Format

BiotechnologyCalifornia, United States201-500 Employees

Relypsa has been renamed and is now known as Vifor Pharma, marking the final stage of its integration under the Vifor umbrella and aligning with a focus on iron deficiency, nephrology, and cardio-renal therapies. The company's US office is located in Redwood City, California, and its work draws on a polymer science heritage, exemplified by the development of Veltassa (patiromer) for oral suspension. Operating within the biotechnology research sector, the organization aims to address the needs of patients with severe and chronic diseases.

Vifor Pharma serves clinicians and patients dealing with iron deficiency and kidney-related conditions, offering therapies that address these health challenges. In January 2024, regulatory authorities in the UK opened a CMA investigation related to potential antitrust issues involving the company.

Get verified Relypsa emails free

Company overview Employee directory